Belite Bio Inc (D01) Stock Price & News

All values in USD	Sep. 2025	Des. 2025	Mrt. 2026	Jun. 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	10,31 m	14,62 m	15,66 m	18,21 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	12,71 m	13,45 m	17,02 m	16,69 m
Operating expense	23,02 m	28,08 m	32,68 m	34,91 m
Total operating expenses	23,02 m	28,08 m	32,68 m	34,91 m
Operating income	-23,02 m	-28,08 m	-32,68 m	-34,91 m
Other non operating income	-2,14 m	-417,00 k	5,75 m	6,55 m
EBT including unusual items	-21,69 m	-25,32 m	-26,94 m	-28,36 m
EBT excluding unusual items	-21,69 m	-25,32 m	-26,94 m	-28,36 m
Income tax expense	-	-	-	55,00 k
Effective tax rate	-	-	-	-0,19%
Other operating expenses	-	-	-	-
Net income	-21,69 m	-25,32 m	-26,94 m	-28,41 m
Net profit margin	-	-	-	-
Earnings per share	-0,65	-0,70	-0,68	-0,70
Interest and investment income	3,47 m	3,17 m	-	-
Interest expense	-	-2,00 k	-	-
Net interest expenses	3,47 m	3,17 m	-	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-22,97 m	-28,03 m	-32,64 m	-34,86 m
Gain or loss from assets sale	-	-	-	-

Finance